新生儿红斑狼疮相关进展研究
Study on the Progress Related to Neonatal Lupus Erythematosus
DOI: 10.12677/acm.2024.1441338, PDF,   
作者: 谭术军, 努尔亚·热加甫*:新疆医科大学,新疆 乌鲁木齐
关键词: 新生儿新生儿红斑狼疮Newborn Neonatal Lupus Erythematosus
摘要: 新生儿红斑狼疮(Neonatal lupus erythematosus, NLE)是一种罕见的结缔组织病,可以影响多个器官,包括皮肤、心脏、肝脏、骨髓和中枢神经系统。其发病机制与母体内自身抗体(抗干燥综合征A抗体和抗干燥综合征B抗体)通过胎盘进入胎儿体内引起的多器官、系统免疫损伤有关。NLE的主要临床表现是皮肤损害和先天性心脏传导阻滞(Congenital heart block, CHB),也可能累及肝脏和血液系统。罕见的情况下,多个系统同时受累。先天性心脏传导阻滞是NLE最严重的表现,病死率高,预后较差。因此,对具有高危因素的母亲,应加强围产期管理,以便早期诊断和干预。为了改善NLE患儿的预后,我们需要进一步深入研究其发病机制和防治策略。本综述对新生儿红斑狼疮在病因、临床表现、治疗和预后等方面的研究进展进行的总结。
Abstract: Neonatal lupus erythematosus (NLE) is a rare connective tissue disease that can affect multiple organs, including skin, heart, liver, bone marrow, and central nervous system. Its pathogenesis is related to the multi-organ and systemic immune damage caused by maternal autoantibodies (anti-Sjögren syndrome A antibodies and anti-Sjögren syndrome B antibodies) entering the fetus through the placenta. The main clinical manifestations of NLE are skin lesions and congenital heart block (CHB), which may also involve the liver and blood system. Rarely, multiple systems are affected simultaneously. Congenital heart block is the most serious manifestation of NLE, with high mortality and poor prognosis. Therefore, perinatal management should be strengthened for mothers with high-risk factors to facilitate early diagnosis and intervention. In order to improve the prognosis of children with NLE, we need to further study its pathogenesis and prevention and treatment strategies. This review summarizes the research progress on the etiology, clinical manifestations, treatment and prognosis of neonatal lupus erythematosus.
文章引用:谭术军, 努尔亚·热加甫. 新生儿红斑狼疮相关进展研究[J]. 临床医学进展, 2024, 14(4): 2626-2630. https://doi.org/10.12677/acm.2024.1441338

参考文献

[1] Costedoat-Chalumeau, N., Morel, N., Fischer-Betz, R., et al. (2019) Routine Repeated Echocardiographic Monitoring of Fetuses Exposed to Maternal Anti-SSA Antibodies: Time to Question the Dogma. Lancet Rheumatol, 1, E187-E193. [Google Scholar] [CrossRef
[2] Vanoni, F., Lava, S.A.G., Fossali, E.F., et al. (2017) Neonatal Systemic Lupus Erythematosus Syndrome: A Comprehensive Review. Clinical Reviews in Allergy & Immunology, 53, 469-476. [Google Scholar] [CrossRef] [PubMed]
[3] Meisgen, S., Hedlund, M., Ambrosi, A., et al. (2022) Auxilin Is a Novel Susceptibility Gene for Congenital Heart Block Which Directly Impacts Fetal Heart Function. Annals of the Rheumatic Diseases, 81, 1151-1161. [Google Scholar] [CrossRef] [PubMed]
[4] Meisgen, S., Östberg, T., Salomonsson, S., et al. (2014) The HLA Locus Contains Novel Foetal Susceptibility Alleles for Congenital Heart Block with Significant Paternal Influence. Journal of Internal Medicine, 275, 640-651. [Google Scholar] [CrossRef] [PubMed]
[5] Gryka-Marton, M., Szukiewicz, D., Teliga-Czajkowska, J., et al. (2021) An Overview of Neonatal Lupus with Anti-Ro Characteristics. International Journal of Molecular Sciences, 22, Article 9281. [Google Scholar] [CrossRef] [PubMed]
[6] Ishikawa, M., Mori, T. and Yamamoto, T. (2020) Neonatal Lupus Erythematosus Exacerbated by Vaccination. The Journal of Dermatology, 47, 1450-1453. [Google Scholar] [CrossRef] [PubMed]
[7] Yu, Y., Du, L., Pan, J., et al. (2016) A 10-Year Retrospective Study of Neonatal Lupus Erythematous in China. Asian Pacific Journal of Allergy and Immunology, 34, 174-178. [Google Scholar] [CrossRef
[8] Yildirim, A., Tunaoolu, F.S. and Karaaoac, A.T. (2013) Neonatal Congenital Heart Block. Indian Pediatrics, 50, 483-488. [Google Scholar] [CrossRef] [PubMed]
[9] Erden, A., Fanouriakis, A., Kiliç, L., et al. (2020) Geoepidemiology and Clinical Characteristics of Neonatal Lupus Erythematosus: A Systematic Literature Review of Individual Patients’ Data. Turkish Journal of Medical Sciences, 50, 281-290. [Google Scholar] [CrossRef] [PubMed]
[10] Brito-Zerón, P., Izmirly, P.M., Ramos-Casals, M., et al. (2015) The Clinical Spectrum of Autoimmune Congenital Heart Block. Nature Reviews Rheumatology l, 11, 301-312. [Google Scholar] [CrossRef] [PubMed]
[11] Chang, C. (2012) Neonatal Autoimmune Diseases: A Critical Review. Journal of Autoimmunity, 38, J223-J238. [Google Scholar] [CrossRef] [PubMed]
[12] Chang, C. (2013) The Pathogenesis of Neonatal Autoimmune and Autoinflammatory Diseases: A Comprehensive Review. Journal of Autoimmunity, 41, 100-110. [Google Scholar] [CrossRef] [PubMed]
[13] Khayat, A.A. and Alkhaldi, A.J. (2022) Neonatal Lupus Presenting with Neonatal Hemochromatosis-Like Liver Disease That Responded to Steroids: A Case Report. BMC Pediatrics, 22, Article No. 630. [Google Scholar] [CrossRef] [PubMed]
[14] Song, J.Y., Park, S.E., Byun, J.H., et al. (2021) Neonatal Lupus Erythematosus as a Rare Cause of Fever in Young Infants. Journal of Clinical Medicine, 10, Article 3195. [Google Scholar] [CrossRef] [PubMed]
[15] Shin, Y., Kang, J.M. and Ahn, J.G. (2020) A Case of Neonatal Lupus Presenting with Fever and Skin Rash in a 47-Day-Old Girl. Pediatric Emergency Medicine, 8, 38-41. [Google Scholar] [CrossRef
[16] Shiiya, C. and Ota, M. (2017) Facial Rash, Fever, and Anemia in A Newborn. JAMA: The Journal of the American Medical Association, 317, 2125-2126. [Google Scholar] [CrossRef] [PubMed]
[17] Kartheeka, M.G., Kumaran, U., Rao, N.N., et al. (2021) Neonatal Lupus Erythematosus Presenting as Neonatal Acute Liver Failure. Indian Journal of Pediatrics, 88, 375-376. [Google Scholar] [CrossRef] [PubMed]
[18] Khurana, A., Maria, A., Sardana, K., et al. (2019) Congenital Scars: A Rare Presentation of Neonatal Lupus. ADC Fetal & Neonatal Edition, 104, F630. [Google Scholar] [CrossRef] [PubMed]
[19] Derdulska, J.M., Rudnicka, L., Szykut-Badaczewska, A., et al. (2021) Neonatal Lupus Erythematosus—Practical Guidelines. Journal of Perinatal Medicine, 49, 529-538. [Google Scholar] [CrossRef] [PubMed]
[20] Johnson, B. (2014) Overview of Neonatal Lupus. Journal of Pediatric Health Care, 28, 331-341. [Google Scholar] [CrossRef] [PubMed]
[21] Zhou, K.Y. and Hua, Y.M. (2017) Autoimmune-Associated Congenital Heart Block: A New Insight in Fetal Life. Chinese Medical Journal, 130, 2863-2871. [Google Scholar] [CrossRef] [PubMed]
[22] Tunaoglu, F.S., Yildirim, A. and Vurali, D. (2010) Isolated Congenital Heart Block. Texas Heart Institute Journal, 37, 579-583.
[23] Izmirly, P.M., Kim, M.Y., Llanos, C., et al. (2010) Evaluation of the Risk of Anti-SSA/Ro-SSB/La Antibody-Associated Cardiac Manifestations of Neonatal Lupus in Fetuses of Mothers with Systemic Lupus Erythematosus Exposed to Hydroxychloroquine. Annals of the Rheumatic Diseases, 69, 1827-1830. [Google Scholar] [CrossRef] [PubMed]
[24] Izmirly, P.M., Costedoat-Chalumeau, N., Pisoni, C.N., et al. (2012) Maternal Use of Hydroxychloroquine Is Associated with a Reduced Risk of Recurrent Anti-SSA/Ro-Antibody-Associated Cardiac Manifestations of Neonatal Lupus. Circulation, 126, 76-82. [Google Scholar] [CrossRef
[25] Martínez-Sánchez, N., Pérez-Pinto, S., Robles-Marhuenda, Á., et al. (2017) Obstetric and Perinatal Outcome in Anti-Ro/SSA-Positive Pregnant Women: A Prospective Cohort Study. Immunologic Research, 65, 487-494. [Google Scholar] [CrossRef] [PubMed]
[26] Barsalou, J., Costedoat-Chalumeau, N., Berhanu, A., et al. (2018) Effect of in Utero Hydroxychloroquine Exposure on the Development of Cutaneous Neonatal Lupus Erythematosus. Annals of the Rheumatic Diseases, 77, 1742-1749. [Google Scholar] [CrossRef] [PubMed]
[27] Izmirly, P., Kim, M., Friedman, D.M., et al. (2020) Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers. Journal of the American College of Cardiology, 76, 292-302. [Google Scholar] [CrossRef] [PubMed]
[28] Hoffmann, J.H.O. and Enk, A.H. (2019) High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease. Frontiers in Immunology, 10, Article 1090. [Google Scholar] [CrossRef] [PubMed]
[29] Enk, A.H., Hadaschik, E.N., Eming, R., et al. (2016) European Guidelines (S1) on the Use of High-Dose Intravenous Immunoglobulin in Dermatology. Journal of the European Academy of Dermatology and Venereology, 30, 1657-1669. [Google Scholar] [CrossRef] [PubMed]
[30] 张利, 米荣, 王晓颖,等. 静脉注射人免疫球蛋白治疗45例新生儿红斑狼疮的疗效[J]. 中国新药与临床杂志, 2023, 42(6): 378-382.